RNASEQ-BASED BIOMARKERS IDENTIFY TARGETABLE BIOLOGIC DRIVERS OF KIDNEY CANCER

$1,037,997FY2022Defense Health AgencyDOD

Vanderbilt University Medical Center, Nashville TN

Investigators